The preparation and characterisation of tasteless core-shell clarithromycin microcapsules

This study aims to fabricate core-shell clarithromycin (CAM) microcapsules to cover up the bitter taste of CAM by spray drying with aqueous polymer dispersion. Water dispersion of Eudragit EPO and Surelease® were innovatively used to encapsulate CAM into microcapsules via a one-step spray-drying method. The inlet air temperature, airflow rate, CAM-polymer ratio, and particle size of CAM were optimised based on drug content and T6% (the time taken for the drug to release equal to 6% w/w). The powder properties were assessed by measuring particle size and microstructure using SEM, FT-IR, and PXRD. Furthermore, selected batch was assessed for their drug content, encapsulation efficiency, in vitro release, bitterness, and stability studies. EPO-Surelease® (1: 4) microcapsules had an average diameter (D50) of 37.69 ± 3.61 μm with a span of 2.395. The drug contents and encapsulation efficiency of EPO-Surelease®(1:4) were 10.89% and 63.7%, respectively. EPO-Surelease® (1:4) microcapsules prepared by spray drying with aqueous polymer dispersion can effectively mask the bitter taste of CAM.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:39

Enthalten in:

Journal of microencapsulation - 39(2022), 7-8 vom: 07. Nov., Seite 654-667

Sprache:

Englisch

Beteiligte Personen:

Fu, Yu [VerfasserIn]
Zhu, Yunjing [VerfasserIn]
Liang, Xue [VerfasserIn]
Kong, Yihan [VerfasserIn]
Wang, Xiaolin [VerfasserIn]
Zhang, Anan [VerfasserIn]
Zhao, Zhiqing [VerfasserIn]
Gou, Jingxin [VerfasserIn]
Wang, Yanjiao [VerfasserIn]
Yin, Tian [VerfasserIn]
Zhang, Yu [VerfasserIn]
He, Haibing [VerfasserIn]
Tang, Xing [VerfasserIn]

Links:

Volltext

Themen:

059QF0KO0R
Aqueous polymer dispersion
Capsules
Clarithromycin
H1250JIK0A
Journal Article
Microcapsules
Polymers
Spray drying
Tasteless
Water

Anmerkungen:

Date Completed 13.01.2023

Date Revised 13.01.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/02652048.2022.2146221

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM349887209